Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
268.09
167.13
131.31
196.25
241.54
186.42
120.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
268.09
167.13
131.31
196.25
241.54
186.42
120.28
Raw Material Cost
47.26
46.33
43.29
77.10
96.27
56.14
53.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.71
3.04
0.66
1.80
19.62
27.42
35.74
Selling and Distribution Expenses
93.65
81.55
52.79
70.06
46.79
64.44
41.88
Other Expenses
7.65
1.84
2.48
3.44
1.26
2.97
-0.52
Total Expenditure (Excl Depreciation)
222.09
149.31
121.49
183.41
175.29
177.69
126.00
Operating Profit (PBDIT) excl Other Income
46
17.8
9.8
12.8
66.3
8.7
-5.699999999999999
Other Income
32.00
74.85
54.49
30.58
32.88
11.15
850.90
Operating Profit (PBDIT)
112.90
135.25
101.73
86.81
140.46
47.85
888.91
Interest
4.71
3.04
0.66
1.80
19.62
27.42
35.74
Exceptional Items
84.47
-92.31
0.00
-5.61
-7.30
-3.00
-12.80
Gross Profit (PBDT)
220.83
120.80
88.03
119.14
145.27
130.28
66.70
Depreciation
33.70
37.38
37.41
43.39
41.34
27.97
43.73
Profit Before Tax
158.96
2.52
63.66
36.01
72.20
-10.54
796.64
Tax
34.51
6.55
9.84
41.23
-4.15
-7.55
167.34
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
124.45
-4.03
53.82
-5.22
76.35
-2.98
629.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
124.45
-4.03
53.82
-5.22
76.35
-2.98
629.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
124.45
-4.03
53.82
-5.22
76.35
-2.98
629.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,017.21
830.44
700.91
597.49
821.16
709.52
767.23
Earnings per share (EPS)
6.13
-0.22
2.94
-1.98
3.31
-0.18
31.85
Diluted Earnings per share
6.13
-0.22
2.94
-1.98
3.31
-0.18
31.85
Operating Profit Margin (Excl OI)
17.61%
13.77%
7.48%
6.54%
27.43%
4.68%
-4.76%
Gross Profit Margin
71.86%
23.87%
76.97%
40.46%
47.01%
9.35%
698.67%
PAT Margin
46.42%
-2.41%
40.98%
-2.66%
31.61%
-1.6%
523.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 60.44% vs 27.27% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 3,212.50% vs -107.43% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 33.94% vs 27.97% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 56.67% vs 328.57% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Ligand Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
268.09
158.18
109.91
69.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
268.09
158.18
109.91
69.48%
Raw Material Cost
47.26
17.21
30.05
174.61%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.71
0.00
4.71
Selling and Distribution Expenses
93.65
120.59
-26.94
-22.34%
Other Expenses
7.65
14.81
-7.16
-48.35%
Total Expenditure (Excl Depreciation)
222.09
285.93
-63.84
-22.33%
Operating Profit (PBDIT) excl Other Income
46.00
-127.75
173.75
136.01%
Other Income
32.00
18.45
13.55
73.44%
Operating Profit (PBDIT)
112.90
-105.51
218.41
207.00%
Interest
4.71
0.00
4.71
Exceptional Items
84.47
0.00
84.47
Gross Profit (PBDT)
220.83
140.97
79.86
56.65%
Depreciation
33.70
3.79
29.91
789.18%
Profit Before Tax
158.96
-109.30
268.26
245.43%
Tax
34.51
-1.98
36.49
1,842.93%
Provisions and contingencies
0
0
0.00
Profit After Tax
124.45
-107.32
231.77
215.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
124.45
-107.32
231.77
215.96%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
124.45
-107.32
231.77
215.96%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,017.21
441.16
576.05
130.58%
Earnings per share (EPS)
6.13
-1.04
7.17
689.42%
Diluted Earnings per share
6.13
-1.04
7.17
689.42%
Operating Profit Margin (Excl OI)
17.61%
-80.76%
0.00
98.37%
Gross Profit Margin
71.86%
-66.70%
0.00
138.56%
PAT Margin
46.42%
-67.85%
0.00
114.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 26.81 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 60.44% vs 27.27% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 12.45 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 3,212.50% vs -107.43% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.09 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 33.94% vs 27.97% in Dec 2024
Annual - Interest
Interest 0.47 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 56.67% vs 328.57% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.61%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
